Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Maravai Lifesciences Holdings (MRVI) Leases: 2021-2024

Historic Leases for Maravai Lifesciences Holdings (MRVI) over the last 2 years, with Dec 2024 value amounting to $78.6 million.

  • Maravai Lifesciences Holdings' Leases changed negligibly% to $78.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $78.6 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $78.6 million for FY2024, which is negligibly% changed negligibly from last year.
  • Latest data reveals that Maravai Lifesciences Holdings reported Leases of $78.6 million as of Q4 2024, which was down 0.00% from $78.6 million recorded in Q4 2023.
  • In the past 5 years, Maravai Lifesciences Holdings' Leases ranged from a high of $80.6 million in Q2 2023 and a low of $47.2 million during Q2 2022.
  • Moreover, its 3-year median value for Leases was $71.9 million (2023), whereas its average is $68.4 million.
  • Data for Maravai Lifesciences Holdings' Leases shows a peak YoY surged of 70.59% (in 2023) over the last 5 years.
  • Maravai Lifesciences Holdings' Leases (Quarterly) stood at $49.1 million in 2021, then spiked by 30.15% to $63.9 million in 2022, then grew by 23.01% to $78.6 million in 2023, then remained steady at $78.6 million in 2024.
  • Its Leases stands at $78.6 million for Q4 2024, versus $78.6 million for Q4 2023 and $76.7 million for Q3 2023.